» Articles » PMID: 33447575

Apparent Diffusion Coefficient Magnetic Resonance Imaging (ADC-MRI) in the Axillary Breast Cancer Lymph Node Metastasis Detection: a Narrative Review

Abstract

The presence of axillary lymph nodes metastases in breast cancer is the most significant prognostic factor, with a great impact on morbidity, disease-related survival and management of oncological therapies; for this reason, adequate imaging evaluation is strictly necessary. Physical examination is not enough sensitive to assess breast cancer nodal status; axillary ultrasonography (US) is commonly used to detect suspected or occult nodal metastasis, providing exclusively morphological evaluation, with low sensitivity and positive predictive value. Currently, sentinel lymph node biopsy (SLNB) and/or axillary dissection are the milestone for the diagnostic assessment of axillary lymph node metastases, although its related morbidity. The impact of magnetic resonance imaging (MRI) in the detection of nodal metastases has been widely investigated, as it continues to represent the most promising imaging modality in the breast cancer management. In particular, diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) values represent additional reliable non-contrast sequences, able to improve the diagnostic accuracy of breast cancer MRI evaluation. Several studies largely demonstrated the usefulness of implementing DWI/ADC MRI in the characterization of breast lesions. Herein, in the light of our clinical experience, we perform a review of the literature regarding the diagnostic performance and accuracy of ADC value as potential pre-operative tool to define metastatic involvement of nodal structures in breast cancer patients. For the purpose of this review, PubMed, Web of Science, and SCOPUS electronic databases were searched with different combinations of "axillary lymph node", "breast cancer", "MRI/ADC", "breast MRI" keywords. All original articles, reviews and metanalyses were included.

Citing Articles

Value of enhanced CT machine learning models combined with clinicoradiological characteristics in predicting lymphatic tissue metastasis in colon cancer.

Li X, Tang Z, Liu Y, Du Y, Xing Y, Zhang Z Radiologie (Heidelb). 2025; .

PMID: 39903282 DOI: 10.1007/s00117-024-01412-y.


Prediction of axillary nodal burden using preoperative magnetic resonance imaging scoring in patients with clinically node-negative breast cancer: a retrospective cohort study.

Wangjitraluck N, Pipatpajong S Gland Surg. 2025; 13(12):2288-2299.

PMID: 39822365 PMC: 11733638. DOI: 10.21037/gs-24-379.


Value of magnetic resonance imaging radiomics features in predicting histologic grade of invasive ductal carcinoma of the breast.

Yang X, Ni D, Yu Y, Zhao J, Lin R, Xiu C Technol Health Care. 2024; 32(3):1609-1618.

PMID: 38393931 PMC: 11091567. DOI: 10.3233/THC-230671.


MRI Evaluation of Rectal Cancer Lymph Node Staging Using Apparent Diffusion Coefficient.

Pikuniene I, Saladzinskas Z, Basevicius A, Straksyte V, Zilinskas J, Ambraziene R Cureus. 2023; 15(9):e45002.

PMID: 37701166 PMC: 10493462. DOI: 10.7759/cureus.45002.


The comparison between young and old patients and the prognostic roles of magnetic resonance imaging-related parameter characteristics in young patients-a retrospective cohort study.

Hu L, Jiang J, Wang X Gland Surg. 2023; 12(4):465-473.

PMID: 37200928 PMC: 10186169. DOI: 10.21037/gs-23-84.


References
1.
Cipolla V, Santucci D, Guerrieri D, Drudi F, Meggiorini M, de Felice C . Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma. Eur J Radiol. 2014; 83(12):2144-2150. DOI: 10.1016/j.ejrad.2014.09.015. View

2.
Travieso-Aja M, Maldonado-Saluzzi D, Naranjo-Santana P, Fernandez-Ruiz C, Severino-Rondon W, Rodriguez Rodriguez M . Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions. Radiol Med. 2019; 124(10):1006-1017. DOI: 10.1007/s11547-019-01056-2. View

3.
Park S, Moon W, Cho N, Song I, Chang J, Park I . Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology. 2010; 257(1):56-63. DOI: 10.1148/radiol.10092021. View

4.
Murphy B, Fazzio R, Hoskin T, Glazebrook K, Keeney M, Habermann E . Management of the axilla in metaplastic breast carcinoma. Gland Surg. 2018; 7(2):200-206. PMC: 5938275. DOI: 10.21037/gs.2018.01.01. View

5.
Ogura A, Hayakawa K, Miyati T, Maeda F . The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol. 2008; 15(7):867-72. DOI: 10.1016/j.acra.2007.12.020. View